Rethinking Folic Acid Fortification: A Pharmacogenomic and Policy-Based Reappraisal of Neural Tube Defect Trends
Bibliographic record
Abstract
This investigative research critically re-evaluates the widely accepted attribution of reduced neural tube defect (NTD) rates in Canada to folic acid fortification. Drawing on a parallel timeline analysis, the study identifies and contextualises several significant pharmacological and regulatory changes - specifically the concurrent withdrawal or restriction of known teratogenic anticonvulsants - that occurred during the implementation of fortification policy. The analysis integrates historical prescribing data, known teratogenic mechanisms, and the chronological overlap of drug market exits with declining NTD incidence. Evaluation reveals that these co-occurring variables represent substantial confounding factors. In addition, the paper incorporates a research synthesis on the biochemical limitations of synthetic folic acid, including the role of unmetabolised folic acid (UMFA), differential receptor binding, and genetic utilisation variance. The collated findings challenge the prevailing narrative that fortification was responsible for improved NTD outcomes and suggest an ongoing triple hit hypothesis; involving MTHFR susceptibility, anti-seizure medication (ASM) exposure, and hidden folate and B12 insufficiency as a plausible driver of paradoxical neural tube defect trends in the UK. This compilation highlights that a reassessment of causality is required in population-level nutrition policy to safeguard public health. Pharmacogenomic and nutritional profiling, including assessment of B12 and folate sufficiency, should be prioritised in women of reproductive age before the prescribing of anti-seizure medications. This analysis underscores the need for rigorous pharmacological context in public health modelling and offers an evidence-based call for transparency in attributing outcomes to broad scale interventions.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.009 | 0.047 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.003 | 0.004 |
| Science and technology studies | 0.001 | 0.003 |
| Scholarly communication | 0.005 | 0.002 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.002 | 0.003 |
| Insufficient payload (model declined to judge) | 0.003 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".